Alice McCarthy

Knowing they’ve inherited a genetic mutation for stomach or breast cancer gives patients the power to plan ahead.

Monitoring and managing effects of transplantation can be a waiting game.

Deep in the bone marrow lies the reason for blood disorders classified as myelodysplastic syndromes—stem cells gone awry.

Allogeneic stem cell transplantation and improvements in conditioning treatments may make transplant available to more patients and lower risk of severe side effects.

Some cancer researchers are questioning whether clinical trial designs should be updated.